Unique ID issued by UMIN | UMIN000004792 |
---|---|
Receipt number | R000005703 |
Scientific Title | Phase II study of pre-emptive therapy for low-level positive cytomegalovirus antigenemia by low-dose valganciclovir after allogeneic hematopoietic stem cell transplantation |
Date of disclosure of the study information | 2011/01/01 |
Last modified on | 2014/06/30 10:00:09 |
Phase II study of pre-emptive therapy for low-level positive cytomegalovirus antigenemia by low-dose valganciclovir after allogeneic hematopoietic stem cell transplantation
Pre-emptive therapy for low-level positive cytomegalovirus antigenemia by low-dose valganciclovir after allogeneic hematopoietic stem cell transplantation
Phase II study of pre-emptive therapy for low-level positive cytomegalovirus antigenemia by low-dose valganciclovir after allogeneic hematopoietic stem cell transplantation
Pre-emptive therapy for low-level positive cytomegalovirus antigenemia by low-dose valganciclovir after allogeneic hematopoietic stem cell transplantation
Japan |
Patients with low-level positive cytomegalovirus antigenemia after allogeneic hematopoietic stem cell transplantation
Hematology and clinical oncology |
Malignancy
NO
Efficacy of low-dose valganciclovir for low-level positive cytomegalovirus antigenemia after allogeneic hematopoeitic stem cell transplantation
Safety,Efficacy
Exploratory
Pragmatic
Phase II
Efficacy of low-dose valganciclovir for low-level positive cytomegalovirus antigenemia
Safety of low-dose valganciclovir
Incidence of cytomegalovirus-associated disease
Interventional
Single arm
Non-randomized
Open -no one is blinded
Historical
1
Treatment
Medicine |
valganciclovir
20 | years-old | <= |
70 | years-old | > |
Male and Female
After allogeneic hematopoietic stem cell transplantation
Low-level positive cytomegalovirus antigenemia (C7-HRP >=2/50,000WBCs and <10/50,000WBCs)
No cytomegalovirus-associated disease
Patients who can take medicines perorally
Performance status 0-2
No major organ complication
Negative cytomegalovirus antibodies of both of donors and recipients
T-cell depleted or CD34-positive cell selected transplantation
Gut GVHD (>=stage 2)
HLA more than 2 locus disparity
20
1st name | |
Middle name | |
Last name | Koichi Akashi |
Kyushu University Hospital
Dept of Hematology/Oncology
3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan
092-642-5230
akashi@intmed1.med.kyushu-u.ac.jp
1st name | |
Middle name | |
Last name | Katsuto Takenaka |
Kyushu University Hospital
Dept of Hematology/Oncology
3-1-1 Maidashi Higashi-ku, Fukuoka 812-8582, Japan
092-642-5230
takenaka@intmed1.med.kyushu-u.ac.jp
Dept of Hematology/Oncology, Kyushu University Hospital, Fukuoka, Japan
none
Self funding
Kurume Unversity Hospital, Fukuoka, Japan
Hamanomachi Hospital, Fukuoka, Japan
Harasanshin Hospital, Fukuoka, Japan
NO
九州大学病院(福岡県),久留米大学病院(福岡県),浜の町病院(福岡県),原三信病院(福岡県)
2011 | Year | 01 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2009 | Year | 09 | Month | 09 | Day |
2009 | Year | 12 | Month | 01 | Day |
2011 | Year | 06 | Month | 01 | Day |
2011 | Year | 12 | Month | 01 | Day |
2011 | Year | 12 | Month | 01 | Day |
2011 | Year | 12 | Month | 01 | Day |
2010 | Year | 12 | Month | 26 | Day |
2014 | Year | 06 | Month | 30 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000005703
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |